| __timestamp | Celldex Therapeutics, Inc. | Geron Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 20622000 | 16758000 |
| Thursday, January 1, 2015 | 33837000 | 17793000 |
| Friday, January 1, 2016 | 35979000 | 18761000 |
| Sunday, January 1, 2017 | 25003000 | 19287000 |
| Monday, January 1, 2018 | 19269000 | 18707000 |
| Tuesday, January 1, 2019 | 15426000 | 20893000 |
| Wednesday, January 1, 2020 | 14456000 | 25678000 |
| Friday, January 1, 2021 | 20488000 | 29665000 |
| Saturday, January 1, 2022 | 27195000 | 43628000 |
| Sunday, January 1, 2023 | 30914000 | 69135000 |
Unleashing the power of data
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Over the past decade, Celldex Therapeutics, Inc. and Geron Corporation have shown contrasting approaches to SG&A cost management. From 2014 to 2023, Celldex's SG&A expenses fluctuated, peaking in 2016 and 2023, with a notable dip in 2019. In contrast, Geron Corporation's SG&A costs have steadily increased, culminating in a dramatic 312% rise from 2014 to 2023. This trend suggests Geron is investing heavily in administrative and sales functions, possibly to support growth initiatives. Meanwhile, Celldex's more variable expenses may indicate a strategic focus on cost control. As investors and stakeholders evaluate these companies, understanding their SG&A strategies provides insight into their operational priorities and financial discipline.
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Celldex Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Takeda Pharmaceutical Company Limited and Geron Corporation
SG&A Efficiency Analysis: Comparing Neurocrine Biosciences, Inc. and Geron Corporation
SG&A Efficiency Analysis: Comparing Bio-Techne Corporation and Geron Corporation
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Celldex Therapeutics, Inc.
Madrigal Pharmaceuticals, Inc. and Geron Corporation: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Xenon Pharmaceuticals Inc. or Celldex Therapeutics, Inc.
Arrowhead Pharmaceuticals, Inc. and Geron Corporation: SG&A Spending Patterns Compared
Arrowhead Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.: SG&A Expense Trends
ImmunityBio, Inc. or Geron Corporation: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Agios Pharmaceuticals, Inc. vs Geron Corporation
Geron Corporation or Novavax, Inc.: Who Manages SG&A Costs Better?